1. Home
  2. MYGN vs ORRF Comparison

MYGN vs ORRF Comparison

Compare MYGN & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.59

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Orrstown Financial Services Inc

ORRF

Orrstown Financial Services Inc

HOLD

Current Price

$36.29

Market Cap

692.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
ORRF
Founded
1991
1919
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
692.0M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
MYGN
ORRF
Price
$4.59
$36.29
Analyst Decision
Buy
Buy
Analyst Count
8
1
Target Price
$7.64
$42.00
AVG Volume (30 Days)
1.7M
153.9K
Earning Date
05-05-2026
04-21-2026
Dividend Yield
N/A
3.33%
EPS Growth
N/A
182.43
EPS
N/A
4.18
Revenue
$771,400,000.00
$37,144,000.00
Revenue This Year
$6.89
N/A
Revenue Next Year
$5.35
$3.08
P/E Ratio
N/A
$8.63
Revenue Growth
2.33
36.00
52 Week Low
$3.76
$25.57
52 Week High
$8.63
$40.72

Technical Indicators

Market Signals
Indicator
MYGN
ORRF
Relative Strength Index (RSI) 46.49 57.98
Support Level $4.24 $32.67
Resistance Level $5.69 $38.12
Average True Range (ATR) 0.29 0.93
MACD -0.00 0.24
Stochastic Oscillator 48.83 87.05

Price Performance

Historical Comparison
MYGN
ORRF

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.

Share on Social Networks: